Učitavanje...
Industry perspectives on biomarker qualification
Biomarkers have the potential to expedite drug development, increase patient safety, and optimize clinical response. Yet few have achieved regulatory qualification. A survey was conducted to clarify industry's perspective on biomarker qualification and identify the most promising biomarkers for...
Spremljeno u:
| Izdano u: | Clin Pharmacol Ther |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5065241/ https://ncbi.nlm.nih.gov/pubmed/26378777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.264 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|